The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Abstract
Tumor progression is a complex, multistage process by which a normal cell undergoes genetic changes that result in phenotypic alterations and the acquisition of the ability to spread and colonize distant sites in the body. Although many factors regulate malignant tumor growth and spread, interactions between a tumor and its surrounding microenvironment result in the production of important protein products that are crucial to each step of tumor progression. The matrix metalloproteinases (MMPs) are a family of degradative enzymes with clear links to malignancy. These enzymes are associated with tumor cell invasion of the basement membrane and stroma, blood vessel penetration, and metastasis. They have more recently been implicated in primary and metastatic tumor growth and angiogenesis, and they may even have a role in tumor promotion. This review outlines our current understanding of the MMP family, including the association of particular MMPs with malignant phenotypes and the role of MMPs in specific steps of the metastatic cascade. As scientific understanding of the MMPs has advanced, therapeutic strategies that capitalize on blocking the enzymes have rapidly developed. The preclinical and clinical evolution of the synthetic MMP inhibitors (MMPIs) is also examined, with the discussion encompassing important methodologic issues associated with determining clinical efficacy of MMPIs and other novel therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Self-citationBiology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
Molecular architecture of basement membranes
Yurchenco, P. D., & Schittny, J. C. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.6.2180767 · Cited by 944
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Goldberg, G. I., Wilhelm, S. M., Kronberger, A., Bauer, E. A., Grant, G. A., & Eisen, A. Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84605-7 · Cited by 632
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., & Matrisian, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1402 · Cited by 609
Self-citationGoss, K. H., Matrisian, L. M., Jensen, R. A., & Rodgers, W. H. (1996) · Europe PMC (PubMed Central) · Cited by 504
Self-citationWolfsberg, T. G., Primakoff, P., Myles, D. G., & White, J. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.2.275 · Cited by 502
Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P., & Basset, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2730 · Cited by 499
Loss of basement membrane components by invasive tumors but not by their benign counterparts.
Barsky, S. H., Siegal, G. P., Jannotta, F. S., & Liotta, L. A. (1983) · PubMed · Cited by 494
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
Murray, G. I., Duncan, M. E., O'Neil, P., Melvin, W. T., & Fothergill, J. E. (1996) · Nature Medicine · doi:10.1038/nm0496–461 · Cited by 481
Kim, J., Yu, W., Kovalski, K., & Ossowski, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81478-6 · Cited by 468
Bernhard, E. J., Gruber, S. B., & Muschel, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4293 · Cited by 385
Davies, B. P., Brown, P. D., East, N., Crimmin, M., & Balkwill, F. R. (1993) · PubMed · Cited by 382
Matrisian, L. M., Glaichenhaus, N., Gesnel, M. C., & Breathnach, R. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03799.x · Cited by 333
Self-citationStromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.
Poulsom, R., Pignatelli, M., Stetler‐Stevenson, W. G., Liotta, L. A., Wright, P. A., Jeffery, R. E., Longcroft, J. M., Rogers, L. A., & Stamp, G. (1992) · PubMed · Cited by 331
Activity of type IV collagenases in benign and malignant breast disease
Davies, B., Miles, D., Happerfield, L., Naylor, M., Bobrow, L., Rubens, R., & Balkwill, F. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.207 · Cited by 323
Schultz, R. M., Silberman, S., Persky, B., et al. (1988) · PubMed · Cited by 311
Masson, R., Lefebvre, O., Noël, A., Fahime, M. E., Chenard, M.-P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.-M., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1535 · Cited by 291
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer
Murray, G. I., Duncan, M. E., O'Neil, P., McKay, J. A., Melvin, W. T., & Fothergill, J. E. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<256::aid-path115>3.0.co;2-a · Cited by 288
Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.
Pyke, C., Ralfkiaer, E. M., Tryggvason, K., & Danø, K. (1993) · PubMed · Cited by 284
Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M., & Okada, Y. (1997) · PubMed · Cited by 280
Brown, P. D. N., Bloxidge, R. E., Stuart, N. S. A., Galler, K. C., & Carmichael, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.7.574 · Cited by 268
Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y., & Seiki, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640513 · Cited by 261
Wagn, X. (1994) · Cancer Research · Cited by 256
Wojtowicz-Praga, S., Torri, J., Johnson, M., Steen, V, Marshall, J., Ness, E., Dickson, R., Sale, M., Rasmussen, H. S., Chiodo, T. A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2150 · Cited by 252
Gress, T. M., Müller‐Pillasch, F., Lerch, M. M., Friess, H., Büchler, M., & Adler, G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620409 · Cited by 233
Chirvi, R. G. S., Garofalo, A., Crimmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., & Giavazzi, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580326 · Cited by 219
Expression of metalloproteinase genes in human prostate cancer
Pajouh, M. S., Nagle, R. B., Breathnach, R., Finch, J. S., Brawer, M. K., & Bowden, G. T. (1991) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01613138 · Cited by 218
Nemunaitis, J. J., Poole, C. J., Primrose, J. M., et al. (1998) · PubMed · Cited by 211
Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia.
Monsky, W. L., Kelly, T. J., Lin, C. Y., Yeh, Y., Stetler‐Stevenson, W. G., Mueller, S. C., & Chen, W. T. (1993) · PubMed · Cited by 207
Wc, P., Jd, K., Navre, M., Grogan, T., Kittelson, J. M., Rb, N., & Bowden, G. T. (1993) · PubMed · Cited by 200
Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.
Stearns, M. E., & Wang, M. (1993) · PubMed · Cited by 198
Sledge, G. W., Qulali, M., Goulet, R., Bone, E. A., & Fife, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1546 · Cited by 194
Interaction of metargidin (ADAM-15) with αvβ3 and α5β1 integrins on different haemopoietic cells
Nath, D., Slocombe, P. M., Stephens, P. E., Warn, A., Hutchinson, G. R., Yamada, K. M., Docherty, A. J. P., & Murphy, G. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.4.579 · Cited by 193
Eccles, S. A., Box, G., Court, W. J., Bone, E. A., Thomas, W., & Brown, P. D. N. (1996) · PubMed · Cited by 191
Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Tumor Metastasis
Sato, H., & Seiki, M. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021223 · Cited by 191
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Witty, J. P., McDonnell, S., Newell, K. J., Cannon, P., Navre, M., Tressler, R. J., & Matrisian, L. M. (1994) · PubMed · Cited by 185
Self-citationWolfsberg, T. G., Bazan, J. F., Blobel, C. P., Myles, D. G., Primakoff, P., & White, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10783 · Cited by 179
Expression and activity of MMPS and their regulators in ovarian cancer
Naylor, M. S., Stamp, G. W., Davies, B. D., & Balkwill, F. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580110 · Cited by 168
Macaulay, V. M., O'Byrne, K. J., Saunders, M. P., et al. (1999) · PubMed · Cited by 161
Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., & Groom, A. C. (1994) · PubMed · Cited by 157
Kinoh, H., Sato, H., Tsunezuka, Y., Takino, T., Kawashima, A., Okada, Y., & Seiki, M. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.953 · Cited by 157
van den Oord, J. J., Paemen, L. R., Opdenakker, G., & Wolf‐Peeters, C. D. (1997) · Europe PMC (PubMed Central) · Cited by 144
D'Armiento, J. M., DiColandrea, T., Dalal, S. S., Okada, Y., Huang, M.-N., Conney, A. H., & Chada, K. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5732 · Cited by 142
Price, A., Shi, Q., Morris, D., Wilcox, M. E., Brasher, P. M. A., Rewcastle, N. B., Shalinsky, D. R., Zou, H. Y., Appelt, K., Johnston, R. N., et al. (1999) · PubMed · Cited by 137
Hamdy, F. C., Fadlon, E., Cottam, D. W., Lawry, J., Thurrell, W., Silcocks, P., Anderson, J., Williams, J., & Rees, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.30 · Cited by 136
Expression of activated gelatinase in human invasive breast carcinoma
Brown, P. D., Bloxidge, R. E., Anderson, E. D. C., & Howell, A. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00114976 · Cited by 134
Gohji, K., Fujimoto, N., Hara, I., Fujii, A., Gotoh, A., Okada, H., Arakawa, S., Kitazawa, S., Miyake, H., Kamidono, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f · Cited by 134
Tsunezuka, Y., Kinoh, H., Takino, T., Watanabe, Y., Okada, Y., Shinagawa, A., Sato, H., & Seiki, M. (1996) · PubMed · Cited by 122
Beattie, G. J., & Smyth, J. F. (1998) · PubMed · Cited by 111
Koop, S., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Khokha, R., Grattan, M., Leone, J., Chambers, A. F., & Groom, A. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11080 · Cited by 111
MT-MMP expression and localisation in human lung and breast cancers
Polette, M., Nawrocki‐Raby, B., Tournier, J. M., Birembaut, P. L., Gilles, C., Sato, H., & Seiki, M. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192924 · Cited by 108
Stromelysin in tumor progression and metastasis
Donnell, S. M., & Matrisian, L. M. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00049521 · Cited by 107
Self-citationAnderson, I. C., Shipp, M. A., Docherty, A., & Teicher, B. A. (1996) · PubMed · Cited by 105
MacDougall, J. R., Bani, M. R., Lin, Y., Rak, J. W., & Kerbel, R. S. (1995) · PubMed · Cited by 104
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
Nielsen, B. S., Sehested, M., Kjeldsen, L., Borregaard, N., Rygaard, J., & Danø, K. (1997) · PubMed · Cited by 93
Bramhall, S. R., Stamp, G., Dunn, J., Lemoine, N. R., & Neoptolemos, J. P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.190 · Cited by 93
Polette, M., Gilbert, N., Nawrocki‐Raby, B., Birembaut, P. L., Stas, I., N�el, A., Remacle, A., Foidart, J. M., & Stetler‐Stevenson, W. G. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01069745 · Cited by 91
Giavazzi, R., Garofalo, A., Ferri, C., Lucchini, V., Bone, E. A., Chiari, S., Brown, P. D. N., Nicoletti, M. I., & Taraboletti, G. (1998) · PubMed · Cited by 86
Da, F., Bafetti, L. M., & Ms, S. (1996) · PubMed · Cited by 80
Takeha, S., Fujiyama, Y., Bamba, T., Sorsa, T. A., Nagura, H., & Ohtani, H. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00304.x · Cited by 76
Zervos, E. E., Norman, J. G., Gower, W. R., Franz, M., & Rosemurgy, A. S. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5086 · Cited by 64
Zeng, Z., & Guillem, J. G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.511 · Cited by 62
Evidence that a functional fertilin-like ADAM plays a role in human spermoolemmal interactions
BRONSON, R. A. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.5.433 · Cited by 53
Multifocal accumulation of p53 protein in esophageal carcinoma: Evidence for field cancerization
Tian, D., Feng, Z., Hanley, N. M., Setzer, R. W., Mumford, J. L., & DeMarini, D. M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981123)78:5<629::aid-ijc17>3.0.co;2-8 · Cited by 34
Hirte, H. W., Goel, R., Major, P. P., Seymour, L. W., Huan, S. D., Stewart, D. E., Yau, J., Arnold, A., Holohan, S., Waterfield, B., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008347630465 · Cited by 32
Infrequent CDKN2 mutation in human differentiated thyroid cancers
Tung, W. S., Shevlin, D. W., Bartsch, D. K., Norton, J. A., Wells, S. A., & Goodfellow, P. J. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199601)15:1<57::aid-mc8>3.0.co;2-p · Cited by 27
Ikeda, T., Murakami, K., Hayakawa, Y., Fujii, H., Ohkoshi, M., & SAIKI, I. (1998) · PubMed · Cited by 11
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“Thus like the many proteins they modify, the MMPs influence diverse physiologic and pathologic processes, including aspects of embryonic development, tissue morphogenesis, wound repair, inflammatory diseases, and cancer (Nelson et al. 2000, Sternlicht et al. 2001).”
BackgroundReactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Self-citationNishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
Metadata
- Authors
- Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-03-01
- Volume
- 18
- Issue
- 5
- Pages
- 1135-1135
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1886431664
- Cited by
- 1,554
- References
- 79
- FWCI
- 36.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.